Why High Court has restrained Glenmark ?
Glenmark an Indian generic drug manufacturer launched the drug “Zita/Zita-met” in the market in 2013. The drug is composed of Sitagliptin, a phosphate salt which is used in the treatment of diabetes. The salt is sold under the tradename Januvia by Merck Sharp and Dohme. After the subsequent launch of “Zita/Zita-met” by Glenmark, an infringement [...]





